SMILEBroadening the vision of success

Over 1 million

treated eyes

worldwide

// RELIABILITY MADE BY ZEISS

Creating success with a SMILE.ZEISS ReLEx SMILE

A minimally invasive success story turns 10

As can be observed in various surgical specialties, there is a growing trend toward minimally invasive procedures and applications. With small incision lenticule extraction, better known as SMILE, that trend has also become the standard for Laser Vision Correction.

First performed on a human eye some ten years ago, SMILE has quickly proven its clinical effectiveness and overall attractiveness – for surgeons and patients alike. It is already transforming refractive surgery as we know it.

2006

2011

2007

Introduction of the ZEISS VisuMax femtosecond laser

Walter Sekundo performs the first SMILE procedure on a sighted patient

SMILE enters the market with the commercial launch of ReLEx® SMILE

Seeing the possibilities in minimally invasive surgery

A great smile is a powerful asset. It gets people’s attention, builds trust and creates opportunities – much like the minimally invasive treatment procedure SMILE. With over 1 million treated eyes already and practiced in all major markets around the world, SMILE provides great prospects for enhancing your clinically services spectrum and your success.

Learn more on www.zeiss.com/smile

2017

2017

First commercial cases in US

Over 1 million successfully treated eyes worldwide

Scan the QR code with your SmartPhone to find out more about SMILE.

EN_3

4_01

0_00

11II

Prin

ted

in G

erm

any.

CZ

-V/2

017

Inte

rnat

iona

l edi

tion:

Onl

y fo

r sal

e in

sel

ecte

d co

untri

es.

The

cont

ents

of t

he b

roch

ure

may

diff

er fr

om th

e cu

rrent

sta

tus

of a

ppro

val o

f the

pro

duct

or s

ervi

ce o

fferin

g in

you

r cou

ntry

. Ple

ase

cont

act o

ur re

gion

al s

ales

re

pres

enta

tives

for m

ore

info

rmat

ion.

Sub

ject

to c

hang

es in

des

ign

and

scop

e of

del

iver

y an

d du

e to

ong

oing

tech

nica

l dev

elop

men

t. Vi

suM

ax a

nd R

eLEx

are

ei

ther

trad

emar

ks o

r reg

ister

ed tr

adem

arks

of C

arl Z

eiss

Med

itec

AG o

r oth

er c

ompa

nies

of t

he Z

EISS

Gro

up.

© C

arl Z

eiss

Med

itec

AG, 2

017.

All

right

s re

serv

ed.

Carl Zeiss Meditec AG Goeschwitzer Strasse 51–52 07745 Jena Germany www.zeiss.com/smile www.zeiss.com/med/contacts

0297